Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities

The number of systemic anticancer therapy (SACT) regimens has expanded rapidly over the last decade with the introduction of immunotherapy, small molecule targeted cancer medicines, and cell therapies. There is a need to ensure quality of SACT delivery across cancer services and systems in different resource settings to reduce morbidity, mortality, and detrimental economic impact at individual and systems level. Existing literature on SACT focuses on treatment efficacy with few studies on quality or how SACT is delivered within routine care in comparison to radiation and surgical oncology.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research